Pulmonx Q3 Net Loss Narrows 40% to $8.39 Million

Pulmonx reported third-quarter 2026 revenue of $22.8 million, up 6% year over year, and a net loss of $8.4 million. Gross margin was 76%, while Adjusted EBITDA loss narrowed to $3.5 million. The company maintained its full-year revenue outlook and updated its expectations for gross margin and opera…